Article: article from journal or magazin.
Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents.
Publication types: Evaluation Studies ; Journal Article - Publication Status: ppublish
Our objective was to evaluate efficacy and patency of metallic stent placement for symptomatic Budd-Chiari syndrome (BCS) due to prothrombotic disorders. Eleven patients with proved BCS due to prothrombotic disorders were referred for endovascular treatment because of refractory ascites (n=9), abdominal pain (n=8), jaundice (n=6), and/or gastrointestinal bleeding (n=4). Stents were inserted for stenosed hepatic vein (n=7), inferior vena cava (n=2), or mesenterico-caval shunt (n=2). Clinical efficacy and stent patency was evaluated by clinical and Doppler follow-up. After a mean follow-up of 21 months, 6 patients had fully patent stents without reintervention (primary stent patency: 55%). Two patients with hepatic vein stenosis had stent thrombosis and died 4 months after procedure. Restenosis occurred in 3 cases (2 hepatic vein and 1 mesenterico-caval shunt stenosis) and were successfully treated by balloon angioplasty (n=2) and addition of new stents (n=1) leading to a 82% secondary stent patency. Of 9 patients with patent stent, 7 were asymptomatic (77%) at the end of the study. Stent placement is a safe and effective procedure to control of symptomatic BCS. Prothrombotic disorder does not seem to jeopardize patency in anticoagulated patients.
Adult, Angioplasty, Balloon, Budd-Chiari Syndrome, Female, Follow-Up Studies, Hepatic Veins, Hepatic Veno-Occlusive Disease, Humans, Male, Mesenteric Veins, Middle Aged, Phlebography, Recurrence, Stents, Thrombophilia, Vascular Patency, Vena Cava, Inferior
Web of science
Last modification date